BiomX Inc. (PHGE) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$5.41M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$1.30M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$8.54M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$7.43M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$5.41M | (m) | (m) | (m) | (m) | -$1.17M* | (m) | (m) | (m) | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$1.30M | (m) | (m) | (m) | (m) | -$5.41M | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$8.54M | (m) | (m) | (m) | (m) | -$7.18M* | (m) | $6.12M | (m) | $3.00K |
|---|
| 2025-06-30 | Reported | (m) | -$7.43M | (m) | (m) | (m) | (m) | -$6.11M* | (m) | $5.01M | (m) | $2.00K |
|---|
| 2025-03-31 | Reported | (m) | -$7.76M | (m) | (m) | (m) | (m) | -$8.71M | (m) | $5.25M | (m) | $1.00K |
|---|
| 2024-09-30 | Reported | (m) | -$11.33M | (m) | (m) | (m) | $10.00K* | -$8.10M* | (m) | $7.28M | (m) | $0.00* |
|---|
| 2024-06-30 | Reported | (m) | -$9.72M | (m) | (m) | (m) | (m) | -$11.24M* | (m) | $6.90M | (m) | $5.00K |
|---|
| 2024-03-31 | Reported | (m) | -$6.79M | (m) | (m) | (m) | (m) | -$11.36M | (m) | $4.11M | (m) | $5.00K |
|---|
| 2023-09-30 | Reported | (m) | -$7.79M | (m) | (m) | (m) | $32.00K* | -$5.92M* | (m) | $5.64M | (m) | $8.00K |
|---|
| 2023-06-30 | Reported | (m) | -$6.07M | (m) | (m) | (m) | $1.00K* | -$4.08M* | (m) | $3.82M | (m) | $8.00K |
|---|
| 2023-03-31 | Reported | (m) | -$6.21M | (m) | (m) | (m) | $10.00K | -$5.04M | (m) | $4.56M | (m) | $6.00K |
|---|
| 2022-09-30 | Reported | (m) | -$6.55M | (m) | (m) | (m) | $6.00K* | -$5.48M* | (m) | $3.54M | (m) | $8.00K |
|---|
| 2022-06-30 | Reported | (m) | -$7.32M | (m) | (m) | (m) | $54.00K* | -$9.09M* | (m) | $4.58M | (m) | $9.00K |
|---|
| 2022-03-31 | Reported | (m) | -$7.79M | (m) | (m) | (m) | $20.00K | -$7.36M | (m) | $4.93M | (m) | $9.00K |
|---|
| 2021-09-30 | Reported | (m) | -$9.83M | (m) | (m) | (m) | $1.31M* | -$5.68M* | (m) | $6.61M | (m) | $10.00K |
|---|
| 2021-06-30 | Reported | (m) | -$7.30M | (m) | (m) | (m) | $790.00K* | -$6.45M* | (m) | $3.82M | (m) | $3.00K |
|---|
| 2021-03-31 | Reported | (m) | -$8.54M | (m) | (m) | (m) | $1.48M | -$6.35M | (m) | $5.67M | (m) | $3.00K |
|---|
| 2020-09-30 | Reported | (m) | -$8.83M | (m) | (m) | (m) | $193.00K* | -$5.92M* | (m) | $6.06M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$6.39M | (m) | (m) | (m) | $189.00K* | -$4.56M* | (m) | $3.72M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$5.97M | (m) | (m) | (m) | $280.00K | -$6.85M | (m) | $3.53M | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$4.66M | (m) | (m) | (m) | $221.00K* | -$269.86K | (m) | $2.86M | (m) | $47.78K |
|---|
| 2019-06-30 | Reported | (m) | -$4.07M | (m) | (m) | (m) | $629.00K* | -$2.89M* | (m) | $2.86M | (m) | (m) |
|---|
| 2019-03-31 | Reported | (m) | -$3.72M | (m) | (m) | (m) | $137.00K | -$3.04M | (m) | $2.74M | (m) | $69.26K |
|---|
| 2018-12-31 | Reported | (m) | -$15.79K | (m) | (m) | (m) | (m) | -$75.29K* | (m) | (m) | (m) | $8.21K |
|---|
| 2018-09-30 | Reported | (m) | -$650.00 | (m) | (m) | (m) | (m) | -$650.00 | (m) | (m) | (m) | (m) |
|---|
| 2018-03-31 | Reported | (m) | -$1.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$41.47M | (m) | (m) | (m) | $2.00K | -$26.39M | (m) | $21.29M | (m) | $7.00K |
|---|
| 2024-12-31 | Reported | (m) | -$44.52M | (m) | (m) | (m) | $30.00K | -$36.98M | (m) | $24.66M | (m) | $13.00K |
|---|
| 2023-12-31 | Reported | (m) | -$25.35M | (m) | (m) | (m) | $50.00K | -$21.29M | (m) | $16.70M | (m) | $23.00K |
|---|
| 2022-12-31 | Reported | (m) | -$27.22M | (m) | (m) | (m) | $112.00K | -$29.09M | (m) | $16.24M | (m) | $65.00K |
|---|
| 2021-12-31 | Reported | (m) | -$35.46M | (m) | (m) | (m) | $3.68M | -$27.57M | (m) | $22.68M | (m) | $67.00K |
|---|
| 2020-12-31 | Reported | (m) | -$30.26M | (m) | (m) | (m) | $1.01M | -$24.45M | (m) | $19.42M | (m) | (m) |
|---|
| 2019-12-31 | Reported | (m) | -$22.21M | (m) | (m) | (m) | $1.31M | -$17.58M | (m) | $13.49M | (m) | (m) |
|---|
| 2019-09-30 | Rolling | (m) | -$12.46M* | (m) | (m) | (m) | (m) | -$6.27M* | (m) | (m) | (m) | (m) |
|---|
| 2019-06-30 | Reported | (m) | -$404.52K | (m) | (m) | (m) | (m) | -$204.58K | (m) | (m) | (m) | $135.20K |
|---|
| 2019-06-30 | Rolling | (m) | -$7.81M* | (m) | (m) | (m) | (m) | -$6.00M* | (m) | (m) | (m) | (m) |
|---|
| 2018-12-31 | Reported | (m) | -$12.49M | (m) | (m) | (m) | $137.00K | -$11.30M | (m) | $9.13M | (m) | (m) |
|---|